We 
as studies with a heterologous TK promoter resulted in identification of a butyrate-responsive element between -180 and -150 that was found to bind specifically to nuclear factors from butyrate-treated Ros 17/2.8 cells. This butyrate-responsive element may represent a genetic element acted upon by enhancer binding proteins. In summary, the 5' flanking region of the mouse calbindin-D2sk gene contains responsive elements that interact with nuclear factors and may mediate, at least in part, the enhanced expression of this gene by 1,25-(OH)2D3 and butyrate.
The major proteins in intestine and kidney whose synthesis is regulated by vitamin D are calcium binding proteins, known as calbindins. Calbindin-D9k is a Mr 9000 protein that is present in mammalian intestine and calbindin-D28k is a Mr 28, 000 protein that is present in avian intestine and avian and mammalian kidney (1) . It has been suggested that calbindin in these tissues is involved in intracellular calcium translocation (2, 3) . Besides intestine and kidney, the calbindins have been reported in many other tissues, including bone and tissues that are not regulators of serum calcium such as pancreas, brain, uterus, and placenta (1) . The presence of calbindin in tissues that are not regulators of serum calcium suggests that calbindin may indeed have functions other than facilitating calcium diffusion. We recently found that calbindin increases with differentiation. Sodium butyrate induces rat insulinoma cells {RIN-1046; a 8-cell line, which contains both calbindin and receptors for 1,25-dihydroxyvitamin D3 [1, 2D3]} to differentiate to a more islet cell phenotype. Butyrate treatment of these cells was found to increase calbindin protein and mRNA 4-to 8-fold and resulted in a parallel increase in insulin secretion (4) . Thus, calbindin increased in accord with cell differentiation. These findings suggest the possibility that calbindin-D28k, similar to other calcium binding proteins, may play a regulatory role in cellular differentiation, a process that involves changes in intracellular calcium. Although (10) . Hybridization was carried out as described (11) . Positive clones were selected and purified.
Southern Blot Analysis and Isolation of the 5' Flanking Region. Mouse genomic DNA was analyzed by Southern blot hybridization (12) . Fragments containing the 5' flanking region were identified by probing to a 33-mer oligonucleotide probe complementary to the first 11 amino acids of rat calbindin-D28k (13, 14) [there is 95% sequence homology between mouse and rat calbindin-D28k (9) ]. This oligonucleotide was 5'-end-labeled with [y-32P]ATP and polynucleotide kinase (15) . A 1.3-kb Pst fragment that hybridized with the oligomer was subcloned into M13um31 and sequenced by the dideoxynucleotide chain-termination method (16) . DNA sequence analysis of the region of the gene between +1 and +154 indicated that this region is identical to the rat calbindin-D28k sequence +1 to +154 (13, 14 tThe sequence reported in this paper has been deposited in the GenBank data base (accession no. L11891).
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promoter; pHCAT was a gift from M. Tocci, Merck Sharpe & Dohme). For experiments involving deletion analysis, the -1075/+34 fragment was cleaved with Pvu II, Bsm I, Ava III, and Hinfl to create fragments -702/+34, -488/+34, -390/+34, and -175/+ 34, respectively, which were cloned into pHCAT. In addition, for experiments with a heterologous viral thymidine kinase (TK) promoter, a 31-bp sequence corresponding to the region -200 to -169 or a 30-bp sequence corresponding to the region -180 to -150 was synthesized (by Oligos Etc., Guilford, CT) and blunt end ligated at the BamHI site of the pBL2CAT vector upstream from the TK promoter (the pBL2CAT construct was a gift from J. W. Pike, Ligand Pharmaceuticals, San Diego). pAVhVDR, which directs expression of the full-length human vitamin D receptor (VDR), was also a gift of J. W. Pike (17) . Plasmid DNA from all clones was isolated through two cesium chloride gradients by standard protocols (15 (19) . CAT activity was assayed with 50 ,ug of lysate protein as described (20) . CAT activity was quantitated by densitometric scanning of autoradiograms using a Shimadzu CS-9000 U dual-wavelength flying spot scanner (Shimadzu, Columbia, MD). CAT activity was also quantitated by scanning TLC plates with the AMBIS radioanalytic imaging system (San Diego). Cotransfection with the ,-galactosidase reporter gene as a control resulted in no difference in ,B-galactosidase activity (21) under conditions in which changes in CAT activity were observed.
Gel-Retardation Assay. DNA fragments of the mouse calbindin-D28k promoter corresponding to -208/-158 and -180/-150 were labeled with 32p. Nuclear extracts were prepared from Ros 17/2.8 cells treated with 10 nM 1,25-(OH)2D3 or 2 mM sodium butyrate for 48 h and COS cells that had been transfected with pAV-hVDR or mock transfected (nuclear extracts from transfected and nontransfected COS cells were a generous gift of J. W. Pike). The gel-retardation assay was performed as described (20) CAT construct, we found that treatment with estradiol (100 nM; using phenol red-free medium) or dexamethasone (100 nM) also did not result in increased CAT activity (data not shown). However, the 5' flanking region was found to mediate a dose-dependent stimulation by sodium butyrate, a differentiating agent that has been reported to modulate expression of a number of genes (24) including calbindin (4) [an 8-fold induction is observed at 2 mM sodium butyrate ( Fig. 2) ].
We next used deletion mutant analysis (Fig. 3) to identify regions involved in basal and inducible expression of calbindin-D28k. Based on our findings with butyrate ( Fig. 2) , we also treated cells with 1,25-(OH)2D3 in the presence of butyrate to test the possibility that butyrate may activate factors that may be involved in a 1,25-(OH)2D3-dependent response. Deletion mutant analysis indicated that basal CAT expression increased 5-to 6-fold with the deletion of 587 bp of upstream sequence (data not shown), suggesting the presence of an upstream repressor sequence. In addition, deletion analysis indicated that the sequences involved in butyrate-mediated induction of CAT activity were located in the -175/+34 fragment (Fig. 3) . Besides this direct effect, a segment located between -702 and -488 was consistently found to confer a 1,25-(OH)2D3-dependent increase in CAT activity in the presence of butyrate (Fig. 3B) . Incubation of cells in the (Fig. 3D) . In this region, the sequences between -198 and -176 have homology to the rat (25, 26) and human (27) 10 nM, and 5-fold at 100 nM (P < 0.05); Fig. 4A ), indicating that 1,25-(OH)2D3 responsiveness can be observed with this specific homologous segment cloned upstream from a heterologous promoter.
To examine whether the region containing the homologous calbindin promoter sequences binds to nuclear factors, gelretardation assays were performed. Incubation of a 32P-labeled probe (calbindin promoter sequences -208/-158) with the Ros cell nuclear extracts resulted in a specific DNA-protein interaction, as indicated by a band of retarded mobility (Fig. 4Ba,  lane 2) . Addition of unlabeled oligonucleotide representing the calbindin VDRE (-200/-169) or unlabeled nucleotide representing the rat osteocalcin VDRE (-469/-433) specifically competed with the probe, and this competition was demonstrated by abolishing the band of retarded mobility (lanes 4 and 5, respectively). However, addition of a nonspecific fragment from the promoter region did not compete with the probe (lane 3) . In addition, when the calbindin-D 28k fragment, which included the sequences homologous to the rat osteocalcin VDRE, was incubated with nuclear extracts from 1,25-(OH)2D3-treated COS cells that had been transfected with pAV-hVDR (Fig. 4Bb, lane 1 (Fig. 4C) , thus suggesting a direct role for VDR in 1,25-(OH)2D3-dependent transcriptional regulation of calbindin-D28k.
After identifying the vitamin D responsive region in the calbindin promoter, we analyzed the butyrate responsive region, which we had found to be located in the -175/+34 fragment. After transfection of a -78/+34 CAT construct (obtained by using Mae I restriction enzyme), we found that CAT activity was not enhanced by butyrate (Fig. 5A) , suggesting that the butyrate responsive region is located between -175 and -78. In this region, sequences located between -172 and -160 were found to contain sequences homologous to a 14-bp fragment in human immunodeficiency virus type 1 long terminal repeat promoter, which has been shown to enhance transcription in response to sodium bu- tyrate by deletion mutant analysis (ref. 28 ; Fig. 5B ). When the -180/-150 fragment was blunt end ligated at the BamHI site of the pBL2CAT vector upstream from the TK promoter, a dose-dependent induction of CAT activity by butyrate was observed (Fig. 5C) In conclusion, these studies result in an increased understanding of the molecular mechanisms involved in regulation of the calbindin-D28k gene. Our studies suggest that further definition of not only transcriptional but also posttranscriptional mechanisms involved in 1,25-(OH)2D3 action is needed to further our understanding of the regulatory mechanisms involved in the multiple actions of the vitamin D endocrine system. In addition, it will be of interest in future studies to further define the VDRE and the butyrate response element and to examine the responsiveness of the calbindin promoter to estrogen (37) and retinoic acid (38) in order to obtain increased insight into multiple steroid interactions as well as interactions of various transcription factors that may be involved in regulation of calbindin gene expression. This work was supported by National Institutes of Health Grant DK38961 to S.C.
